Literature DB >> 16952134

Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.

Marion Jurk1, Andrea Kritzler, Harald Debelak, Jörg Vollmer, Arthur M Krieg, Eugen Uhlmann.   

Abstract

Synthetic oligodeoxynucleotides containing unmethylated deoxycytidylyl-deoxyguanosine dinucleotide (CpG) motifs are able to stimulate potent immune responses through a signaling pathway involving Toll-like receptor 9 (TLR9). We have investigated the structure-activity relationship (SAR) of base-modified CpG oligonucleotides with TLR9 by measuring TLR9 activation by 20-mer oligonucleotides having just a single human recognition motif (5'-GTCGTT-3') in functional cell-based TLR9 assays. Substitution of guanine by hypoxanthine and 6-thioguanine resulted in activity similar to the unmodified parent molecule, whereas purine, 2-aminopurine, 2,6-diaminopurine, and 8-oxo-7,8-dihydroguanine substitution resulted in approximately 40-60 % reduction in activity, and 7-deazaguanine substitution led to the strongest (80 %) reduction in TLR9 stimulation. Furthermore, none of the investigated modifications at C5 and N4 of cytosine were well tolerated with respect to human TLR9 stimulation. Our results are compatible with a SAR model in which guanine is recognized by the Hoogsteen site, and C5 is most critical for recognition of cytosine. In addition, we found significant species-specific differences between human and murine TLR9 recognition, which demonstrates the importance of choosing appropriate assay systems for SAR studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952134     DOI: 10.1002/cmdc.200600064

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  8 in total

1.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

2.  Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects).

Authors:  Cordula Weber; Christian Müller; Anja Podszuweit; Carmen Montino; Jörg Vollmer; Alexandra Forsbach
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice.

Authors:  Jeffrey M Duggan; Dahui You; Jeffrey O Cleaver; Derek T Larson; R Joshua Garza; Francisco A Guzmán Pruneda; Michael J Tuvim; Jiexin Zhang; Burton F Dickey; Scott E Evans
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

4.  Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.

Authors:  Alyssa L Siefert; Michael J Caplan; Tarek M Fahmy
Journal:  Biomaterials       Date:  2016-04-01       Impact factor: 15.304

5.  Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia.

Authors:  Michael J Tuvim; Brian E Gilbert; Burton F Dickey; Scott E Evans
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

Review 6.  TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

Authors:  Christopher R Shepard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

7.  S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.

Authors:  Takayuki Nakagawa; Tetsuya Tanino; Motoyasu Onishi; Soichi Tofukuji; Takayuki Kanazawa; Yukichi Ishioka; Takeshi Itoh; Akira Kugimiya; Kazufumi Katayama; Takuya Yamamoto; Morio Nagira; Ken J Ishii
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

8.  Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.

Authors:  Tokuyuki Yoshida; Kunihiko Morihiro; Yuki Naito; Atsushi Mikami; Yuuya Kasahara; Takao Inoue; Satoshi Obika
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.